Clover Health Investments Future Growth
Future criteria checks 0/6
Clover Health Investments's revenue is forecast to decline at 2.4% per annum while its annual earnings are expected to grow at 19.8% per year. EPS is expected to grow by 20.2% per annum. Return on equity is forecast to be -16.8% in 3 years.
Key information
19.8%
Earnings growth rate
20.2%
EPS growth rate
Healthcare earnings growth | 19.3% |
Revenue growth rate | -2.4% |
Future return on equity | -16.8% |
Analyst coverage | Low |
Last updated | 13 Sep 2024 |
Recent future growth updates
Recent updates
Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success
Aug 15Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Aug 14Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Aug 06Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jun 12Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues
Apr 20Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07Chamath Palihapitiya-linked Clover Health Investments trading near all-time low
Oct 14Chamath Palihapitiya cuts stake in Clover Health to under 5%
Oct 04Rethinking My Clover Health Position
Sep 12Clover Paid The Price Of Its Alleged Lies; Time To Move On
Aug 17Clover Health Investments to name president Andrew Toy as CEO
Aug 08Clover Health Is A Buy Ahead Of Earnings
Jul 29Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2
Jul 15Is Clover Health A Good Healthcare Sector Stock Pick?
Jun 30Clover Set To Report Earnings Tonight: Levels To Watch
May 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,560 | -54 | N/A | N/A | 2 |
12/31/2025 | 1,465 | -61 | N/A | N/A | 3 |
12/31/2024 | 1,385 | -67 | N/A | N/A | 3 |
6/30/2024 | 2,090 | -121 | -178 | -177 | N/A |
3/31/2024 | 2,059 | -157 | -170 | -169 | N/A |
12/31/2023 | 2,036 | -213 | -116 | -116 | N/A |
9/30/2023 | 2,040 | -234 | -183 | -178 | N/A |
6/30/2023 | 2,441 | -268 | -63 | -58 | N/A |
3/31/2023 | 2,989 | -344 | -155 | -150 | N/A |
12/31/2022 | 3,579 | -340 | -291 | -286 | N/A |
9/30/2022 | 3,041 | -443 | -76 | -75 | N/A |
6/30/2022 | 2,564 | -402 | -222 | -222 | N/A |
3/31/2022 | 2,075 | -615 | -247 | -246 | N/A |
12/31/2021 | 1,361 | -588 | -283 | -282 | N/A |
9/30/2021 | 1,158 | -527 | -263 | -262 | N/A |
6/30/2021 | 922 | -487 | -252 | -252 | N/A |
3/31/2021 | 721 | -160 | -175 | -174 | N/A |
12/31/2020 | 690 | -136 | -119 | -118 | N/A |
9/30/2020 | 624 | -89 | -126 | -126 | N/A |
6/30/2020 | 572 | -145 | -116 | -116 | N/A |
3/31/2020 | 507 | -272 | -163 | -163 | N/A |
12/31/2019 | 455 | -364 | -160 | -160 | N/A |
12/31/2018 | 281 | -202 | -155 | -153 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLOV is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CLOV is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CLOV is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CLOV's revenue is expected to decline over the next 3 years (-2.4% per year).
High Growth Revenue: CLOV's revenue is forecast to decline over the next 3 years (-2.4% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CLOV is forecast to be unprofitable in 3 years.